As part of Psoriasis Action Month, Alisha Bridges, an award-winning writer and community advocate, recently shared her story about living with psoriasis.

UCB supports local events across the country that benefit patients. Recently, our employees participated in two different runs in support of the epilepsy and Crohn’s disease communities.

FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

An estimated 3.3 million individuals in the U.S. are living with spondyloarthritis^1,2 (SpA), an inflammatory disease affecting the spine, and in some people, the joints of the arms and legs, skin, intestines, and eyes. An underdiagnosed condition, most people with SpA first experience symptoms in their 20s or 30s but typically wait as many as 10 years between symptom onset and SpA diagnosis. * 

August is Psoriasis Awareness Month so we’re shining a spotlight on the disease and how UCB is working to deliver solutions that patients value.